# Over 70% of MS Patients in Rehab Take 5+ Medications, Study Finds > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/polypharmacy-ms-rehabilitation-medication-burden/ > **Published:** 2026-03-31T18:07:19-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:33:45-04:00 > **Clinical Summary:** Explore polypharmacy in MS rehabilitation and how cannabis may reduce medication burden for better symptom management in MS patients. --- ✦ New CED Clinical Relevance  #80High Clinical Relevance  Strong evidence or policy relevance with direct clinical implications. ⚒ Cannabis News  |  CED Clinic Multiple SclerosisPolypharmacySpasticity[Pain Management](https://cedclinic.com/cbd-cbg-topicals-for-eczema/)Neurological Conditions Why This Matters This polypharmacy finding in MS rehabilitation patients highlights a critical clinical scenario where cannabis may offer therapeutic consolidation opportunities. When patients are managing 5+ medications, each with distinct side effect profiles and drug interactions, identifying single agents that address multiple symptoms becomes clinically valuable. Clinical Summary A study of MS patients in rehabilitation settings found over 70% were taking five or more concurrent medications, representing significant polypharmacy burden. This finding reflects the complex symptom management challenges in MS, including spasticity, pain, sleep disturbance, mood disorders, and neurogenic bladder issues that often require multiple pharmaceutical interventions. The polypharmacy pattern is particularly pronounced in rehabilitation settings where symptom severity may be higher. Dr. Caplan’s Take “When I see MS patients on this many medications, I’m immediately thinking about therapeutic efficiency and [drug interaction](https://cedclinic.com/glp-1-addiction-risk-reduction-benefits/) risks. Cannabis offers a unique opportunity here because it can potentially address multiple MS symptoms — spasticity, pain, sleep, mood — with a single agent that has minimal drug interactions.” Clinical Perspective 🧠 Clinicians should systematically review medication lists in MS patients, particularly those in rehabilitation. Consider whether cannabis could safely replace or reduce multiple symptomatic treatments while maintaining efficacy. The key is careful titration and monitoring to ensure symptom control is maintained as traditional medications are potentially reduced. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Over%2070%25%20of%20MS%20patients%20in%20rehab%20take%205%20or%20more%20medications%2C%20study%20finds%20%40drcaplan&url=https%3A//multiplesclerosisnewstoday.com/news-posts/2026/03/31/70-percent-ms-rehabilitation-patients-take-minimum-5-medications-study/)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A//multiplesclerosisnewstoday.com/news-posts/2026/03/31/70-percent-ms-rehabilitation-patients-take-minimum-5-medications-study/)[🦥 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Over%2070%25%20of%20MS%20patients%20in%20rehab%20take%205%20or%20more%20medications%2C%20study%20finds%20--%20via%20%40drcaplan.bsky.social%20https%3A//multiplesclerosisnewstoday.com/news-posts/2026/03/31/70-percent-ms-rehabilitation-patients-take-minimum-5-medications-study/)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) 📰 Source: [https://multiplesclerosisnewstoday.com/news-posts/2026/03/31/70-percent-ms-rehabilitation-patients-take-minimum-5-medications-study/](https://multiplesclerosisnewstoday.com/news-posts/2026/03/31/70-percent-ms-rehabilitation-patients-take-minimum-5-medications-study/) Table of Contents - [FAQ](#FAQ)[What is the clinical relevance rating of this cannabis research?](#What_is_the_clinical_relevance_rating_of_this_cannabis_research) - [What medical conditions does this cannabis study focus on?](#What_medical_conditions_does_this_cannabis_study_focus_on) - [What is polypharmacy and why is it relevant to this study?](#What_is_polypharmacy_and_why_is_it_relevant_to_this_study) - [How does cannabis help with Multiple Sclerosis symptoms?](#How_does_cannabis_help_with_Multiple_Sclerosis_symptoms) - [Is this cannabis research applicable to current clinical practice?](#Is_this_cannabis_research_applicable_to_current_clinical_practice) - [Related](#Related) ## FAQ #### What is the clinical relevance rating of this cannabis research? This research has been assigned a “High Clinical Relevance” rating (#80) by CED Clinical. This indicates strong evidence or policy relevance with direct clinical implications for [patient care](https://cedclinic.com/cannabis-cardiovascular-risk-impact/). #### What medical conditions does this cannabis study focus on? The study primarily focuses on Multiple Sclerosis patients experiencing spasticity. It also addresses [pain management](https://cedclinic.com/cbd-cbg-topicals-for-eczema/) concerns in this patient population. #### What is polypharmacy and why is it relevant to this study? Polypharmacy refers to the use of multiple medications simultaneously by a patient. This study examines how cannabis may interact with or potentially reduce the need for multiple medications in MS patients. #### How does cannabis help with Multiple Sclerosis symptoms? Cannabis may help manage MS-related spasticity and pain symptoms. The research suggests it could be a therapeutic option for patients who experience these debilitating symptoms of Multiple Sclerosis. #### Is this cannabis research applicable to current clinical practice? Yes, this research has direct clinical implications for healthcare providers treating MS patients. The high clinical relevance rating suggests the findings can inform treatment decisions and [patient care](https://cedclinic.com/cannabis-cardiovascular-risk-impact/) strategies. {“@context”: “https://schema.org”, “@type”: “NewsArticle”, “headline”: “Over 70% of MS patients in rehab take 5 or more medications, study finds”, “url”: “https://multiplesclerosisnewstoday.com/news-posts/2026/03/31/70-percent-ms-rehabilitation-patients-take-minimum-5-medications-study/”, “datePublished”: “2026-03-31T20:32:11Z”, “about”: “over 70 ms patients rehab take”} [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Cannabis-based interventions might help a little with neuropathic pain – Study Summary](https://cedclinic.com/cannabis-neuropathic-pain-relief-modest-benefits/) This study explores the modest benefits of [cannabis-based treatments](https://cedclinic.com/cannabis-medical-clinic-experience-beyond-smoking-vaping/) for [neuropathic pain](https://cedclinic.com/cannabis-for-pain-relief/), relevant to MS symptom management. [Read Study Summary](https://cedclinic.com/cannabis-neuropathic-pain-relief-modest-benefits/) [Older Adults Turn to Cannabis Primarily for Symptom Management – Pulmonology Advisor](https://cedclinic.com/older-adults-turn-to-cannabis-primarily-for-symptom-management-pulmonology-advisor/) Insights into how older adults use cannabis for managing symptoms, highlighting therapeutic consolidation opportunities. [Learn More](https://cedclinic.com/older-adults-turn-to-cannabis-primarily-for-symptom-management-pulmonology-advisor/) [Wim Hof method, lifestyle changes reduce inflammation in new MS study](https://cedclinic.com/wim-hof-method-inflammation-ms-study/) Explore non-pharmaceutical approaches like the Wim Hof method that may complement symptom management in MS rehabilitation. [Explore Findings](https://cedclinic.com/wim-hof-method-inflammation-ms-study/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).